CVS Caremark will add Zydus' Zituvio™ and combination products to its template formulary
Zydus Lifesciences (including its subsidiaries/affiliates, hereafter referred to as 'Zydus'), a global innovation driven healthcare company announced that it has entered into an agreement with CVS Caremark , a CVS Health (NYSE: CVS) company to add Zituvio™, Zituvimet™ and Zituvimet™ XR (Sitagliptin
Disclaimer: No Business Standard Journalist was involved in creation of this content